Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, cost-efficiency and environmental responsibility. SHINE has successfully commercialized fusion across multiple applications, including neutron testing markets such as neutron radiography, radiation-effects testing and fusion material research. It has commercialized and is scaling its proprietary medical isotope production and processes, supplying high-quality radioisotopes essential for procedures including diagnosing heart disease and cancer as well as cancer therapy.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/02/26	$250,000,000		Deerfield Management Company, L.P. Fidelity Management & Research Company NantWorks Oaktree Capital Management Pelican Energy Partners Sumitomo Corporation	undisclosed